Annual Total Long Term Liabilities
$47.23 M
-$6.46 M-12.04%
December 31, 2023
Summary
- As of February 8, 2025, OCX annual total long term liabilities is $47.23 million, with the most recent change of -$6.46 million (-12.04%) on December 31, 2023.
- During the last 3 years, OCX annual total long term liabilities has risen by +$34.29 million (+264.99%).
- OCX annual total long term liabilities is now -41.13% below its all-time high of $80.23 million, reached on December 31, 2021.
Performance
OCX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$51.41 M
+$6.60 M+14.72%
September 30, 2024
Summary
- As of February 8, 2025, OCX quarterly total long term liabilities is $51.41 million, with the most recent change of +$6.60 million (+14.72%) on September 30, 2024.
- Over the past year, OCX quarterly long term liabilities has increased by +$15.42 million (+42.85%).
- OCX quarterly long term liabilities is now -35.91% below its all-time high of $80.23 million, reached on December 31, 2021.
Performance
OCX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
OCX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.0% | +42.9% |
| 3 y3 years | +265.0% | -25.3% |
| 5 y5 years | +8744.6% | -25.3% |
OCX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -41.1% | at low | -35.9% | +45.1% |
| 5 y | 5-year | -41.1% | +931.0% | -35.9% | +1022.4% |
| alltime | all time | -41.1% | -100.0% | -35.9% | -100.0% |
OncoCyte Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $51.41 M(+14.7%) |
| Jun 2024 | - | $44.82 M(-12.2%) |
| Mar 2024 | - | $51.06 M(+8.1%) |
| Dec 2023 | $47.23 M(-12.0%) | $47.23 M(+31.2%) |
| Sep 2023 | - | $35.99 M(-0.8%) |
| Jun 2023 | - | $36.27 M(+2.4%) |
| Mar 2023 | - | $35.44 M(-34.0%) |
| Dec 2022 | $53.69 M(-33.1%) | $53.69 M(-20.5%) |
| Sep 2022 | - | $67.53 M(-1.8%) |
| Jun 2022 | - | $68.80 M(-8.7%) |
| Mar 2022 | - | $75.35 M(-6.1%) |
| Dec 2021 | $80.23 M(+520.0%) | $80.23 M(+44.3%) |
| Sep 2021 | - | $55.62 M(+1.2%) |
| Jun 2021 | - | $54.94 M(+322.9%) |
| Mar 2021 | - | $12.99 M(+0.4%) |
| Dec 2020 | $12.94 M(+182.5%) | $12.94 M(-9.1%) |
| Sep 2020 | - | $14.24 M(-16.3%) |
| Jun 2020 | - | $17.02 M(+6.7%) |
| Mar 2020 | - | $15.95 M(+248.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $4.58 M(+757.9%) | $4.58 M(+1068.6%) |
| Sep 2019 | - | $392.00 K(+292.0%) |
| Jun 2019 | - | $100.00 K(-65.9%) |
| Mar 2019 | - | $293.00 K(-45.1%) |
| Dec 2018 | $534.00 K(-60.7%) | $534.00 K(-30.0%) |
| Sep 2018 | - | $763.00 K(-11.8%) |
| Jun 2018 | - | $865.00 K(-20.9%) |
| Mar 2018 | - | $1.09 M(-19.6%) |
| Dec 2017 | $1.36 M(+338.4%) | $1.36 M(-13.1%) |
| Sep 2017 | - | $1.56 M(-13.9%) |
| Jun 2017 | - | $1.82 M(-1.9%) |
| Mar 2017 | - | $1.85 M(+497.4%) |
| Dec 2016 | $310.00 K(>+9900.0%) | $310.00 K(+46.9%) |
| Sep 2016 | - | $211.00 K(-13.5%) |
| Jun 2016 | - | $244.00 K(>+9900.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2015 | - | $3.30 M(>+9900.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00 |
| Dec 2013 | $0.00 | - |
FAQ
- What is OncoCyte annual total long term liabilities?
- What is the all time high annual total long term liabilities for OncoCyte?
- What is OncoCyte annual total long term liabilities year-on-year change?
- What is OncoCyte quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for OncoCyte?
- What is OncoCyte quarterly long term liabilities year-on-year change?
What is OncoCyte annual total long term liabilities?
The current annual total long term liabilities of OCX is $47.23 M
What is the all time high annual total long term liabilities for OncoCyte?
OncoCyte all-time high annual total long term liabilities is $80.23 M
What is OncoCyte annual total long term liabilities year-on-year change?
Over the past year, OCX annual total long term liabilities has changed by -$6.46 M (-12.04%)
What is OncoCyte quarterly total long term liabilities?
The current quarterly long term liabilities of OCX is $51.41 M
What is the all time high quarterly long term liabilities for OncoCyte?
OncoCyte all-time high quarterly total long term liabilities is $80.23 M
What is OncoCyte quarterly long term liabilities year-on-year change?
Over the past year, OCX quarterly total long term liabilities has changed by +$15.42 M (+42.85%)